UK's Oxford vaccine phase-2 trial indicates strong results in older adults, says Lancet study
UK's Oxford vaccine phase-2 trial indicates strong results in older adults, says Lancet study
newKerala.com
0 shares
1 views
You might like
Related news coverage
Oxford-AstraZeneca Vaccine Shows Promise In Elderly
Newsy
Watch VideoThe Oxford-Astrazeneca vaccine trial has some good news after early data found its candidate is working well in older..
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
Oxford COVID-19 vaccine sees 'encouraging' results in healthy older adults
Mid-Day
Advertisement
More coverage
Oxford scientists expect COVID-19 vaccine data by Christmas
SeattlePI.com
LONDON (AP) — University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by..
-
Oxford-AstraZeneca Covid-19 Vaccine Shows Good Immune Response In Older People
RTTNews
-
AstraZeneca COVID-19 vaccine shows promise in elderly, trial results expected by Christmas
CBC.ca
-
Oxford scientists expect COVID-19 vaccine data by Christmas
SeattlePI.com
-
Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggest
Business Insider